Plasma from coronavirus survivors found to help severely ill patients

Doctors have found tentative evidence that seriously ill coronavirus patients can benefit from infusions of blood plasma collected from people who have recovered from the disease.

Two teams of medics working at separate hospitals in China gave antibody-rich plasma to 15 severely ill patients and recorded striking improvements in many of them.

In one pilot study, doctors in Wuhan gave “convalescent plasma” to 10 severely ill patients and found that virus levels in their bodies dropped rapidly. Within three days, the doctors saw improvements in the patients’ symptoms, ranging from shortness of breath and chest pains to fever and coughs.

Xiaoming Yang, from the National Engineering Technology Research Center for Combined Vaccines in Wuhan, described the treatment as a “promising rescue option” for severely ill patients, but cautioned that a larger randomised trial was needed to confirm the findings. Details of the pilot study are reported in Proceedings of the National Academy of Sciences.

A researcher from University Hospital Erlangen, Germany, which has been granted permission to produce therapeutic plasma to treat critically ill Covid-19 patients. Photograph: Andreas Gebert/Reuters
 A researcher from University Hospital Erlangen, Germany, which has been granted permission to produce therapeutic plasma to treat critically ill Covid-19 patients. Photograph: Andreas Gebert/Reuters

Another team of doctors led by Lei Liu, from Shenzhen Third People’s hospital, gave convalescent plasma to five critically ill patients. All showed improved symptoms after the infusions and within 10 days, three patients were able to come off the ventilators that had been keeping them alive, according to a preliminary report in the Journal of the American Medical Association.

The findings raise hopes that donated blood from recently recovered patients could be used to boost the immune systems of more vulnerable people and help them fight the infection. But with only a small number of patients so far treated with plasma, and the infusions given outside of formal trials, it is impossible to know how much benefit the treatment really brings.

Convalescent plasma treatments date back to before the 1918 Spanish flu pandemic. The therapy relies on the fact that people who have recovered from a viral infection have antibodies in their blood that can rapidly detect and destroy the virus the next time it attacks. Infusing the plasma into patients, and potentially into people at risk of being infected, can boost their immune systems and potentially provide protection.

Hints that the therapy may help have prompted US doctors to trial infusions in the outbreak in New York and similar studies are expected to start in the UK in the coming weeks. Britain’s national blood service has begun screening blood from patients to find plasma rich in antibodies to use in those trials.

Professor David Tappin, a senior research fellow at the University of Glasgow, has applied to the UK’s National Institute for Health Research to run two clinical trials with convalescent plasma. They will look for evidence that plasma can protect frontline workers from infection, prevent patients from deteriorating and needing ventilation in intensive care units, and improve the condition of those who are already severely ill.

Tappin said the cases reported from Wuhan were important because they suggested that giving plasma to severely ill patients appeared to be safe. “The outcomes are also encouraging for these patients,” he said. But he added that to be sure plasma improved on the natural course of the disease, and that it was safe in larger groups of patients, formal trials had to take place.

Professor Munir Pirmohamed, the president of the British Pharmacological Society, echoed the need to be cautious about the Wuhan cases. “This was not a randomised trial and all patients also received other treatments including antivirals such as remdesivir, which are currently in trials for Covid-19,” he said.

“It is also important to remember that there are potential safety concerns with convalescent plasma, including transmission of other agents and antibody enhancement of disease,” he added. “Even if shown to work, scalability to treat large numbers of patients may become an issue.”

The Guardian

Other News

Vietnam joins Artemis Accords on space exploration

Vietnam joins Artemis Accords on space exploration

Vietnam views space science and technology as a strategic sector that can lift national science-technology capacity and support sustainable growth. The country wants to work with member nations on peaceful, safe, equitable, transparent and sustainable space exploration under international law, with tangible benefits for people and the planet.

Vietnam seeks deeper role in global semiconductor value chain

Vietnam seeks deeper role in global semiconductor value chain

As global semiconductor supply chains are restructured, experts said Vietnam’s opportunity lies not only in attracting projects but also in accumulating knowledge, technology and management expertise to move into higher-value activities.

Vietnam moves to standardize digital economy measurement

Vietnam moves to standardize digital economy measurement

The digital economy is a strategic priority for Vietnam, which aims to raise its share of GDP to at least 30% by 2030, in line with the Politburo’s Resolution No. 57-NQ/TW on breakthroughs in science and technology, innovation and national digital transformation.

AI platform launched to help businesses build brands

AI platform launched to help businesses build brands

Addressing the event, experts and business representatives stressed that harnessing digital technologies requires businesses to adopt a new mindset, use data in decision-making, and maintain brand identity and consumer trust.

Top leader calls for greater contribution from Vietnamese experts in Canada

Top leader calls for greater contribution from Vietnamese experts in Canada

At a meeting with representatives of the Canadian Vietnamese Scientists and Experts Association (CVSEA) on September 25 (local time), the top leader praised the contributions and professional capabilities of Vietnamese experts and intellectuals in Canada, describing them as a valuable intellectual resource and an important bridge connecting Vietnam with Canada and the wider world.

Hanoi approves controlled pilot of two technology projects

Hanoi approves controlled pilot of two technology projects

The two projects involve an intelligent autonomous transportation system developed by Phenikaa-X JSC and a technology for producing mixed rare-earth oxides with a purity of over 95% on a semi-industrial scale developed by the Mining Technology and Construction Consultancy JSC.

Banking industry in AI era: When data becomes competitive advantage

Banking industry in AI era: When data becomes competitive advantage

In just a few years, AI has evolved from an experimental technology into an “assistant” for many banks, supporting everything from customer service, credit approval, and fraud detection to risk management. However, as the technological gap between institutions narrows, a new question is emerging: What will determine banks' competitive advantage in the AI era?

Bac Ninh considers establishing AI centre of excellence

Bac Ninh considers establishing AI centre of excellence

A meeting has been held in Bac Ninh to discuss potential cooperation with Plug and Play in developing the northern province’s innovation ecosystem and establishing an artificial intelligence (AI) centre of excellence, with Standing Vice Chairman of the provincial People’s Committee Mai Son receiving a delegation from the global innovation platform.

Hanoi allows 24-month trial of autonomous vehicles at Hoa Lac

Hanoi allows 24-month trial of autonomous vehicles at Hoa Lac

The project aims to assess the safety, reliability and readiness of autonomous vehicles under real traffic conditions, as well as the effectiveness of autonomous public transport and compatibility with existing systems. Its results will contribute to developing technical standards, operating procedures and management models suited to Hanoi’s traffic conditions.

Singapore's experience suggests solutions to Vietnam's human resources challenge in AI era

Singapore's experience suggests solutions to Vietnam's human resources challenge in AI era

As Vietnam accelerates digital transformation and high-tech development, Singapore’s experience and the engagement of global technology companies demonstrate that human resources preparation must stay ahead of the curve. The ability to filter knowledge, collaborate, innovate and effectively use AI will increasingly become essential to helping workers adapt to a changing labour market and strengthening the competitiveness of Vietnam’s economy in the new era.